Vedanta’s consolidated revenue for Q1FY27 reached ₹242 b, a 54% jump from the same period last year and unchanged quarter‑on‑quarter.
The increase was largely due to higher LME prices, premium charges, and favorable foreign‑exchange movements.
EBITDA for the quarter rose to ₹85 b, up 98% YoY and 13% QoQ, driven by the same factors plus higher production volumes.
The EBITDA margin improved to 35.1%, up from 30.7% in Q4FY26 and 27.1% in Q1FY26, signalling better cost control and pricing power.
Current market valuation places the shares at 7.6 times the FY28 projected EBITDA, giving a fair‑value estimate of about ₹290 per share.
The Zinc segment remains the main contributor to earnings, and analysts maintain a neutral recommendation on the stock.